Angiotech moves Vascular Wrap closer to EU
This article was originally published in Clinica
Executive Summary
Angiotech Pharmaceuticals has submitted for marketing in Europe its paclitaxel-eluting Vascular Wrap, a device designed to enhance graft patency rates in peripheral bypass procedures and in AV-access haemodialysis patients.